iopromide has been researched along with Bone Cancer in 2 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ba, L | 1 |
Tan, H | 1 |
Xiao, H | 1 |
Guan, Y | 1 |
Gao, J | 1 |
Gao, X | 1 |
Zhang, WD | 1 |
Zhao, LL | 1 |
Huang, XB | 1 |
Cai, PQ | 1 |
Xu, GX | 1 |
2 other studies available for iopromide and Bone Cancer
Article | Year |
---|---|
Radiologic and clinicopathologic findings of peripheral primitive neuroectodermal tumors.
Topics: Adolescent; Adult; Aged; Bone Neoplasms; Child; Child, Preschool; Contrast Media; Diagnosis, Differe | 2015 |
Computed tomography imaging of anterior and middle mediastinal Ewing sarcoma/primitive neuroectodermal tumors.
Topics: Adolescent; Adult; Biopsy, Needle; Bone Neoplasms; Contrast Media; Female; Humans; Iohexol; Male; Me | 2010 |